Current Developments and Innovations in Early Detection and Subsequent Treatment of Cancer

Objective: The study aimed to identify key trends in modern oncology by analysing developments and innovations in early cancer diagnosis and treatment methods. Using a comparative analysis of scientific and healthcare systems in Albania, Bulgaria, Kyrgyzstan, and Uzbekistan, the study examined innovative diagnostic approaches such as liquid biopsy, biomarker discovery, genetic testing, advanced imaging techniques, and artificial intelligence algorithms. Methods: For treatment, it highlighted immunotherapy, personalised medicine, cellular, targeted, and combination therapies, as well as the development of radiopharmaceuticals and 3D modelling for surgical planning. Results: Key findings revealed that the lack of economic support for research is the primary barrier to innovation in all four countries. Bulgaria, benefiting from European Union membership, demonstrated the highest potential for advancing oncology due to its stronger scientific, technical, regulatory, and social indicators. In contrast, Albania's transition economy and Kyrgyzstan’s social and geographical challenges significantly hinder progress. The findings underline the need for enhanced economic investment, international cooperation, and regulatory support to address disparities and foster the implementation of innovative oncology practices globally. Conclusion: This regional analysis provides insights into how tailored approaches can bridge the gap between low- and high-income countries in advancing cancer care.